Aspirin: not licensed for primary prevention of thrombotic vascular disease

2009-10-03T10:00:00+01:00

In the UK, low-dose aspirin is licensed for prevention of thrombotic cerebrovascular or cardiovascular disease only in those who already have vascular disease—ie, secondary prevention.